{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T07:00:21Z","timestamp":1648969221760},"reference-count":35,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2019.4741","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T10:25:24Z","timestamp":1551781524000},"source":"Crossref","is-referenced-by-count":1,"title":["Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells"],"prefix":"10.3892","author":[{"given":"Corinna","family":"Eberherr","sequence":"first","affiliation":[{"name":"Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, D\u201180337 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Beck","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, D\u201180337 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Vokuhl","sequence":"additional","affiliation":[{"name":"Institute of Paidopathology, Pediatric Tumor Registry, Christian\u2011Albrecht's\u2011University Kiel, D\u201124105 Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Becker","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, D\u201180337 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"H\ufffdberle","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, D\u201180337 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietrich","family":"Von Schweinitz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, D\u201180337 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Kappler","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, D\u201180337 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,3,5]]},"reference":[{"key":"key20200713185744_b1-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-3016.1990.tb00651.x","article-title":"Malignant hepatic tumours in children: Incidence, clinical features and aetiology","volume":"4","author":"Mann","year":"1990","journal-title":"Paediatr Perinat Epidemiol"},{"key":"key20200713185744_b2-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ejca.2005.02.035","article-title":"The emerging family of hepatoblastoma tumours: From ontogenesis to oncogenesis","volume":"41","author":"Zimmermann","year":"2005","journal-title":"Eur J Cancer"},{"key":"key20200713185744_b3-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","article-title":"The genomic landscape of hepatoblastoma and their progenies with HCC-like features","volume":"61","author":"Eichenm\u00fcller","year":"2014","journal-title":"J Hepatol"},{"key":"key20200713185744_b4-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.28888","article-title":"Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups","volume":"65","author":"Sumazin","year":"2017","journal-title":"Hepatology"},{"key":"key20200713185744_b5-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","article-title":"Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas","volume":"95","author":"de La Coste","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185744_b6-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1038\/sj.onc.1205591","article-title":"Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas","volume":"21","author":"Taniguchi","year":"2002","journal-title":"Oncogene"},{"key":"key20200713185744_b7-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1158\/0008-5472.CAN-13-3275","article-title":"\u03b2-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma","volume":"74","author":"Mokkapati","year":"2014","journal-title":"Cancer Res"},{"key":"key20200713185744_b8-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jhep.2014.09.016","article-title":"Unravelling the genetics of hepatoblastoma: Few mutations, what else?","volume":"61","author":"Buendia","year":"2014","journal-title":"J Hepatol"},{"key":"key20200713185744_b9-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nbt.3080","article-title":"A comprehensive transcriptional portrait of human cancer cell lines","volume":"33","author":"Klijn","year":"2015","journal-title":"Nat Biotechnol"},{"key":"key20200713185744_b10-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Cairo","year":"2008","journal-title":"Cancer Cell"},{"key":"key20200713185744_b11-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)64567-1","article-title":"Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome","volume":"157","author":"Weber","year":"2000","journal-title":"Am J Pathol"},{"key":"key20200713185744_b12-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.semcancer.2006.07.015","article-title":"The Myc oncoprotein as a therapeutic target for human cancer","volume":"16","author":"Vita","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"key20200713185744_b13-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(03)01166-5","article-title":"Neuroblastoma: Biology and molecular and chromosomal pathology","volume":"4","author":"Schwab","year":"2003","journal-title":"Lancet Oncol"},{"key":"key20200713185744_b14-ijo-54-05-1853","first-page":"435","article-title":"Transcriptional activities of the Myc and Max proteins in mammalian cells","volume":"182","author":"Kretzner","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"key20200713185744_b15-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrc3984","article-title":"MYC: Connecting selective transcriptional control to global RNA production","volume":"15","author":"Kress","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"key20200713185744_b16-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/hep.22649","article-title":"Blocking the hedgehog pathway inhibits hepatoblastoma growth","volume":"49","author":"Eichenm\u00fcller","year":"2009","journal-title":"Hepatology"},{"key":"key20200713185744_b17-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713185744_b18-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/15476286.2015.1063773","article-title":"MYCNOS functions as an antisense RNA regulating MYCN","volume":"12","author":"Vadie","year":"2015","journal-title":"RNA Biol"},{"key":"key20200713185744_b19-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrc1799","article-title":"Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?","volume":"6","author":"Baylin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"key20200713185744_b20-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccr.2013.05.005","article-title":"Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma","volume":"24","author":"Brockmann","year":"2013","journal-title":"Cancer Cell"},{"key":"key20200713185744_b21-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/2159-8290.CD-13-0018","article-title":"Targeting MYCN: A good BET for improving neuroblastoma therapy?","volume":"3","author":"Schnepp","year":"2013","journal-title":"Cancer Discov"},{"key":"key20200713185744_b22-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1476-4598-10-131","article-title":"Aurora-A inactivation causes mitotic spindle pole fragmentation by unbalancing microtubule-generated forces","volume":"10","author":"Asteriti","year":"2011","journal-title":"Mol Cancer"},{"key":"key20200713185744_b23-ijo-54-05-1853","first-page":"293","article-title":"Pediatric hepatoblastoma: Diagnosis and treatment","volume":"3","author":"Hiyama","year":"2014","journal-title":"Transl Pediatr"},{"key":"key20200713185744_b24-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1097\/MPH.0b013e31821f0eaf","article-title":"Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin","volume":"33","author":"Sivaprakasam","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"key20200713185744_b25-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000360238","article-title":"Cardiotoxicity and cardioprotection in childhood cancer","volume":"132","author":"Lipshultz","year":"2014","journal-title":"Acta Haematol"},{"key":"key20200713185744_b26-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1158\/1535-7163.MCT-11-0623","article-title":"The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells","volume":"11","author":"Sehdev","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"key20200713185744_b27-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2174\/1568009617666170623101722","article-title":"JQ1, a BET inhibitor, synergizes with cisplatin and induces apoptosis in highly chemo-resistant malignant pleural mesothelioma cells","volume":"18","author":"Zanellato","year":"2018","journal-title":"Curr Cancer Drug Targets"},{"key":"key20200713185744_b28-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/genes8060151","article-title":"MYC Deregulation in Primary Human Cancers","volume":"8","author":"Kalkat","year":"2017","journal-title":"Genes (Basel)"},{"key":"key20200713185744_b29-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fonc.2014.00330","article-title":"Editorial: Targeting MYCN in Pediatric Cancers","volume":"4","author":"Sala","year":"2015","journal-title":"Front Oncol"},{"key":"key20200713185744_b30-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/2159-8290.CD-17-0273","article-title":"The Expanding World of N-MYC-Driven Tumors","volume":"8","author":"Rickman","year":"2018","journal-title":"Cancer Discov"},{"key":"key20200713185744_b31-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12885-018-4129-8","article-title":"The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdo-myosarcoma and neuroblastoma cells","volume":"18","author":"O\u2019Brien","year":"2018","journal-title":"BMC Cancer"},{"key":"key20200713185744_b32-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2015.06.015","article-title":"MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma","volume":"366","author":"Beckers","year":"2015","journal-title":"Cancer Lett"},{"key":"key20200713185744_b33-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ng.2436","article-title":"LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression","volume":"44","author":"Molenaar","year":"2012","journal-title":"Nat Genet"},{"key":"key20200713185744_b34-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ccr.2014.06.018","article-title":"Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models","volume":"26","author":"Nguyen","year":"2014","journal-title":"Cancer Cell"},{"key":"key20200713185744_b35-ijo-54-05-1853","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.28621","article-title":"Patient-derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management","volume":"64","author":"Nicolle","year":"2016","journal-title":"Hepatology"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:04:03Z","timestamp":1594667043000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2019.4741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,5]]},"references-count":35,"URL":"https:\/\/doi.org\/10.3892\/ijo.2019.4741","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,5]]}}}